Literature DB >> 21141072

[Molecular mechanisms of preretinal membrane contraction in proliferative vitreoretinal diseases and ROCK as a therapeutic target].

Takeshi Kita1.   

Abstract

Cicatricial contraction of preretinal fibrous membrane is a cause of severe vision loss in proliferative vitreoretinal diseases such as proliferative diabetic retinopathy (PDR) and proliferative vitreoretinopathy (PVR). In this study, vitreous samples from PDR or PVR patients caused significantly stronger contraction of hyalocyte-containing collagen gels, an in vitro model of cicatricial contraction, compared with those from nonproliferative controls. We elucidated the critical role of transforming growth factor-beta (TGF-beta) in the contractile effect and its underlying mechanisms mediating cicatricial contraction in proliferative vitreoretinal diseases at least in part. Fasudil, a potent and selective Rho-kinase (ROCK) inhibitor, almost completely blocked collagen gel contraction induced by vitreous samples. In addition, fasudil significantly inhibited the progression of experimental PVR in rabbit eyes in vivo. Rho/ROCK pathway, considered to be a key downstream mediator of TGF-beta and other contractile-inducing factors, might become a unique therapeutic target for the treatment of proliferative vitreoretinal diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21141072

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  4 in total

Review 1.  [Proliferative vitreoretinopathy process-To heal or not to heal].

Authors:  S Grisanti; S Priglinger; L Hattenbach
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

2.  Proliferative vitreoretinopathy: current and emerging treatments.

Authors:  Ama Sadaka; Gian Paolo Giuliari
Journal:  Clin Ophthalmol       Date:  2012-08-14

Review 3.  Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid.

Authors:  Francesco Morescalchi; Sarah Duse; Elena Gambicorti; Mario R Romano; Ciro Costagliola; Francesco Semeraro
Journal:  Mediators Inflamm       Date:  2013-09-30       Impact factor: 4.711

4.  Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature.

Authors:  Majid Moshirfar; Lawsen Parker; Orry C Birdsong; Yasmyne C Ronquillo; Daniel Hofstedt; Tirth J Shah; Aaron T Gomez; Phillip C Sr Hoopes
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.